前沿论文｜CELL INTELLIGENCE

Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

PubMed 2026/06/18 发表Cancer Cell IntQ1 · IF 7（JCR 2025）

Harnessing CAR-NK cells against multiple myeloma: current landscape and future directions.

PubMed 2026/06/04 发表Mol Biol RepQ3 · IF 3.2（JCR 2025）

CAR-NK 疗法正从一种有前景的概念演变为针对 MM 的现实治疗平台。

Beyond CRISPR: next-gen precision engineering of CAR-NK cells for enhanced persistence, trafficking, and tumor eradication.

PubMed 2026/02/05 发表Cancer Cell IntQ1 · IF 7（JCR 2025）

"Next-Generation Cord Blood Expansion: Bridging the Cell Dose Gap with Bioengineered Niches and Clinical Breakthroughs".

PubMed 2026/01/29 发表Stem Cell Rev RepQ2 · IF 4.9（JCR 2025）

Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.

PubMed 2025/12/27 发表Stem Cell Rev RepQ2 · IF 4.9（JCR 2025）

Overcoming barriers in CAR-NK immunotherapy: CRISPR-Driven advances in checkpoint editing and allogeneic design.

PubMed 2025/12/17 发表Funct Integr GenomicsQ2 · IF 4（JCR 2025）

CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future.

PubMed 2025/10/23 发表J Transl MedQ1 · IF 9.7（JCR 2025）

Tracing the development of CAR-T cell design: from concept to next-generation platforms.

PubMed 2025/07/17 发表Front ImmunolQ1 · IF 7（JCR 2025）

Highlights of 2024: unleashing the power of NK cells-cancer's worst nightmare.

PubMed 2025/06/02 发表Immunol Cell BiolQ3 · IF 3.3（JCR 2025）

CRISPR-Cas9 in basic and translational aspects of cancer therapy.

PubMed 2024/03/10 发表BioimpactsQ3 · IF 2.5（JCR 2025）

CRISPR-Cas9 系统通过靶向参与这些癌症发病机制的关键基因，彻底改变了一些实体恶性肿瘤和白血病的治疗策略。

前沿论文 11